ZyVersa Therapeutics Overview
ZyVersa Therapeutics Discounted Cash Flow
DCF Analysis for ZVSA.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.02
Current Fair Value
$0.02
↓ 91.2% Downside
Overvalued by 91.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison